Journal of Dermatological Science
Volume 59, Issue 2 , Pages 81-85, August 2010

Chemokines and cutaneous lymphoma

  • Makoto Sugaya

      Affiliations

    • Corresponding Author InformationTel.: +81 3 5800 8661; fax: +81 3 3814 1503.

Department of Dermatology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

Received 13 April 2010; accepted 15 May 2010. published online 12 July 2010.

Abstract 

Chemokines are small molecules of 8–10kDa that induce chemotaxis and activation of certain subsets of leukocytes. It has been recently shown that chemokines have broader function such as inhibition of apoptosis of target cells. The expression patterns of chemokines and chemokine receptors are specific to certain organs and cells. Therefore, chemokines are important to elucidate the mechanism of organ-specific human diseases. Primary cutaneous lymphomas are characterized by proliferation of clonally expanded lymphocytes in skin, but without detectable systemic involvement at the first diagnosis. Many chemokines are reported to be expressed in lesional skin of cutaneous lymphoma. Moreover, tumor cells of a certain group of cutaneous lymphoma express limited numbers of chemokine receptors, suggesting that interactions between chemokines and their receptors may explain skin-tropism of these types of lymphoma. This article focuses on chemokines expressed in lesional skin of cutaneous lymphoma and discusses their possible roles in disease progression.

KeywordsChemokines, Cutaneous lymphoma, CXCL13, CCL17, CCL27, CCL26

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0923-1811(10)00184-2

doi:10.1016/j.jdermsci.2010.05.005

Journal of Dermatological Science
Volume 59, Issue 2 , Pages 81-85, August 2010